Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sphingomyelin phosphodiesterase 4 pseudogene 2 (SMPD4P2)
- Target
- SMPD4P2
- Molecular classification
- Pseudogene, Other
01
Overview
Sphingomyelin phosphodiesterase 4 pseudogene 2 (SMPD4P2) is a non-functional, duplicated segment of DNA homologous to the sphingomyelin phosphodiesterase 4 (SMPD4, also known as neutral sphingomyelinase-3) gene[1][7]. As a pseudogene, it does not encode a functional protein product, but its RNA transcript may potentially interact with endogenous RNA regulatory networks, such as competing endogenous RNA (ceRNA) pathways or RNA interference[4][6][8]. Like many pseudogenes, SMPD4P2 may play a regulatory role in gene expression through these non-coding RNA mechanisms, although there is currently no evidence for direct biological or disease-modifying effects specific to this pseudogene. SMPD4P2 is **not** a therapeutic target, receptor, enzyme, or structurally active protein, and there are no known drugs, mechanisms of action, or clinical biomarkers associated with it.
- Other names
- neutral sphingomyelinase 3 pseudogenesphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3) pseudogene 2neutral sphingomyelinase-3 pseudogene 2
02
Biological functions
May regulate gene expression via ceRNA mechanisms (competing endogenous RNA network)Possible involvement in post-transcriptional gene regulation through RNA interference pathways, similar to other pseudogenes
03
Disease associations
Other (association with ceRNA network regulation; not directly implicated as a causative factor in diseases)
Beyond the preview
Go deeper on Sphingomyelin phosphodiesterase 4 pseudogene 2 (SMPD4P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sphingomyelin phosphodiesterase 4 pseudogene 2 (SMPD4P2).